Lisanti Capital Growth’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-159,811
| Closed | -$5.79M | – | 169 |
|
|
2023
Q1 | $5.79M | Sell |
159,811
-223,449
| -58% | -$8.1M | 0.81% | 52 |
|
|
2022
Q4 | $13.7M | Buy |
383,260
+80
| +0% | +$2.85K | 1.87% | 8 |
|
|
2022
Q3 | $13M | Sell |
383,180
-33,470
| -8% | -$1.13M | 1.73% | 16 |
|
|
2022
Q2 | $12.1M | Buy |
416,650
+190,434
| +84% | +$5.51M | 1.64% | 19 |
|
|
2022
Q1 | $7.31M | Sell |
226,216
-78,239
| -26% | -$2.53M | 0.82% | 49 |
|
|
2021
Q4 | $8.88M | Buy |
+304,455
| New | +$8.88M | 1.28% | 21 |
|
|
2018
Q3 | – | Sell |
-60,670
| Closed | -$3.63M | – | 154 |
|
|
2018
Q2 | $3.63M | Buy |
60,670
+19,225
| +46% | +$1.15M | 1.39% | 17 |
|
|
2018
Q1 | $1.9M | Buy |
+41,445
| New | +$1.9M | 0.92% | 47 |
|
|
2017
Q4 | – | Sell |
-25,920
| Closed | -$1.04M | – | 129 |
|
|
2017
Q3 | $1.04M | Sell |
25,920
-42,715
| -62% | -$1.71M | 0.65% | 67 |
|
|
2017
Q2 | $2.96M | Buy |
68,635
+52,380
| +322% | +$2.26M | 1.97% | 5 |
|
|
2017
Q1 | $509K | Sell |
16,255
-27,535
| -63% | -$862K | 0.73% | 72 |
|
|
2016
Q4 | $1.11M | Buy |
43,790
+33,925
| +344% | +$857K | 1.34% | 30 |
|
|
2016
Q3 | $244K | Sell |
9,865
-27,305
| -73% | -$675K | 0.31% | 91 |
|
|
2016
Q2 | $757K | Buy |
+37,170
| New | +$757K | 1.14% | 37 |
|